2023 annual financial data
Revelation Biosciences 2023 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -8,656,664 USD and net income was -120,254 USD.
Operating cash flow was -7,286,286 USD.
Get free Revelation Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -8,656,664 USD
- Net income
- -120,254 USD
- Operating cash flow
- -7,286,286 USD
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Revelation Biosciences financial years